Sana Biotechnology (SANA) Other Accumulated Expenses (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Other Accumulated Expenses data on file, last reported at $1.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Accumulated Expenses rose 16.02% year-over-year to $1.8 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (up 16.02% YoY), and the FY2025 full-year result was $1.6 million, down 9.06% from the prior year.
• Other Accumulated Expenses advanced to $1.8 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $3.7 million in Q3 2024 to a low of $1.3 million in Q3 2025.
• A 5-year average of $2.3 million and a median of $2.1 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses soared 78.9% in 2024 and slumped 64.08% in 2025, its largest moves.
• Tracing SANA's Other Accumulated Expenses over 5 years: stood at $2.9 million in 2022, then declined by 6.42% to $2.7 million in 2023, then sank by 34.6% to $1.8 million in 2024, then dropped by 9.06% to $1.6 million in 2025, then advanced by 11.72% to $1.8 million in 2026.
• Business Quant data shows SANA's Other Accumulated Expenses at $1.8 million in Q1 2026, $1.6 million in Q4 2025, and $1.3 million in Q3 2025.